2020
DOI: 10.18632/aging.102883
|View full text |Cite
|
Sign up to set email alerts
|

Surgical blood loss during holmium laser enucleation of the prostate (HoLEP) is not affected by short-term pretreatment with dutasteride: a double-blind placebo-controlled trial on prostate vascularity

Abstract: Benign prostate enlargement, with related lower urinary tract symptoms (LUTS), is one of the most common diseases for patients who are referred to a urologist. Benign prostate enlargement strongly impacts quality of life and is accompanied by a substantial economic burden [1-2]. Disease management is initially based on watchful waiting and medical therapy. In particular α-blockers are able to increase International Prostate Symptom Scores

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
8
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6

Relationship

2
4

Authors

Journals

citations
Cited by 10 publications
(9 citation statements)
references
References 29 publications
1
8
0
Order By: Relevance
“…In our review, the rate of reoperations for clot evacuation is 0.7%. These values confirm the low postoperative rate of bleeding in HoLEP, which is not affected by short-term treatment with dutasteride [81]. In the case of HoLEP, in addition to bleeding, bladder injury on morcellation and the remains of free nonmorcellated adenoma are other causes of early re-intervention.…”
Section: Discussionsupporting
confidence: 71%
“…In our review, the rate of reoperations for clot evacuation is 0.7%. These values confirm the low postoperative rate of bleeding in HoLEP, which is not affected by short-term treatment with dutasteride [81]. In the case of HoLEP, in addition to bleeding, bladder injury on morcellation and the remains of free nonmorcellated adenoma are other causes of early re-intervention.…”
Section: Discussionsupporting
confidence: 71%
“…However, both the El Tayeb and Warner studies did not report which morcellators were utilized. Busetto et al used the VersaCut ™ morcellator and also reported no difference in morcellation efficiency for the 5-ARI group (5.34 vs. 5.65 g/ min, p=0.44, respectively) (8).…”
Section: Discussionmentioning
confidence: 98%
“…Thus, some men who undergo HoLEP may have had preoperative 5-ARI exposure if they failed combination therapy. The limited available evidence on perioperative outcomes of 5-ARIs prior to HoLEP suggests there are no effects on blood loss (8), enucleation time or morcellation time (9,10). We hypothesized that because 5-ARIs reduce prostate volume by ~20% (11) and increase collagen deposition, increased tissue density could result in prolonged morcellation.…”
Section: Introductionmentioning
confidence: 98%
“…The most widely used are Green Light photoselective vaporization of the prostate (PVP) and laser enucleation techniques, such as Holmium Laser Enucleation of the Prostate (HoLEP) and Thulium Laser Enucleation of the Prostate (ThuLEP). 11 , 12 Even if these approaches have shown to achieve results comparable to the standard technique (ie, TURP) with regards to functional outcomes, only few studies have investigated the cost/ benefit ratio related to these procedures. Indeed, these innovative techniques might present an increased cost in terms of equipment and consumables.…”
Section: Introductionmentioning
confidence: 99%